DIA Euromeeting Glasgow, Scotland- March 29th to the 31st

March 10, 2017

March, 29-31, – Scottish Exhibition & Conference Centre – SECC, Glasgow, Scotland

Ennov, a Regulatory software vendor, exhibits its Regulatory Software Suite at the DIA Euromeeting at the Scottish Exhibition & Conference Center (Stand B6), set to begin on March 29th.
Ennov has a comprehensive PV suite for Human and Veterinary drugs, including a complete pharmacovigilance database and analytics solution.
In the DIA Euromeeting, we will present our eCTD247 solution which enables you to publish PSUR in eCTD format, as mandated by the EMA since June 2016. eCTD247 enables you to submit your eCTD (or NeeS) dossier with the minimum effort and time. We will also be showing our RIM solution to meet your RA deadlines.
eCTD247 is the only online eCTD solution and

As a specialist of eCTD, Ennov has devised the most practical and cost effective solution for submitting PSUR in eCTD or NeeS format.

DIA’s Annual EuroMeeting is an evolving conference which addresses the most pressing issues of today in Healthcare and the future.

This serves as the premier place for the discussion of processes, globalization, patients, and regulation including innovation and technology.

This year’s theme highlights the critical role patient input plays throughout the lifecycle of drug development. Additionally, the clinical content and “HTA, Value & Access” theme are more robust this year in recognizing the growing importance in the market.

About Ennov

Ennov provides a comprehensive software platform to manage the most demanding processes of life sciences organizations in a compliant and efficient way. With over 20 years of experience, Ennov’s cloud-based solutions cover Regulatory Affairs, Pharmacovigilance, Quality, Clinical, and Document Management. Dedicated to innovation and excellence, Ennov’s solutions are used by more than 450 Life Science companies and 500,000 users worldwide, helping them to bring their products to market faster while maintaining compliance with regulatory requirements.

Share :

Facebook
Twitter
LinkedIn

Register for free to access to our library of exclusive content!

Highlight Post

Recent Posts